Funds and ETFs ResMed, Inc.

Equities

RMD

US7611521078

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 09:43:28 2024-06-14 am EDT 5-day change 1st Jan Change
210.9 USD -0.71% Intraday chart for ResMed, Inc. +0.39% +23.46%

ETFs positioned on ResMed, Inc.

Name Weight AuM 1st Jan change Investor Rating
1.09% 21 M€ +8.79% -
1.03% 15 M€ -3.21%
0.73% 204 M€ +10.54%
0.43% 7 M€ +5.53%
0.43% 38 M€ -.--%
0.38% 9 M€ -.--% -
0.38% 2 M€ +9.20%
0.33% 108 M€ +12.18%
0.29% 5 M€ -72.95% -
0.21% 55 M€ +13.32%
0.20% 10 M€ +11.46%
0.20% 252 M€ +7.19%
0.18% 219 M€ +17.17% -
0.18% 1,448 M€ -.--% -
0.18% 2,334 M€ +18.54%
0.16% 825 M€ +12.54%
0.16% 9 M€ +8.22% -
0.16% 36 M€ +22.19%
0.16% 4 M€ -.--% -
0.13% 276 M€ +11.40% -
0.12% 261 M€ -.--% -
0.12% 200 M€ +12.85% -
0.12% 488 M€ +15.78%
0.11% 8 M€ +4.98% -
0.11% 31 M€ -0.17% -
0.11% 20 M€ +4.98% -
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (50.4%); - masks (37.9%); - software as a service (11.7%). At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia. The United States accounts for 61.4% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
212.4 USD
Average target price
218.7 USD
Spread / Average Target
+2.99%
Consensus
  1. Stock Market
  2. Equities
  3. RMD Stock
  4. Funds and ETFs ResMed, Inc.